TRIM39 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.428400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.420400E-01
Normal-vs-Stage2
3.222800E-01
Normal-vs-Stage3
1.137420E-01
Normal-vs-Stage4
4.776600E-01
Stage1-vs-Stage2
3.094800E-01
Stage1-vs-Stage3
1.084220E-01
Stage1-vs-Stage4
7.895400E-01
Stage2-vs-Stage3
2.933200E-01
Stage2-vs-Stage4
2.693200E-01
Stage3-vs-Stage4
4.106100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.484200E-01
Normal-vs-AfricanAmerican
3.525400E-01
Normal-vs-Asian
3.425900E-02
Caucasian-vs-AfricanAmerican
9.855000E-01
Caucasian-vs-Asian
1.844210E-01
AfricanAmerican-vs-Asian
3.589200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.312200E-01
Normal-vs-Female
3.606800E-01
Male-vs-Female
4.210000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.182800E-01
Normal-vs-Age(41-60Yrs)
3.816400E-01
Normal-vs-Age(61-80Yrs)
3.234400E-01
Normal-vs-Age(81-100Yrs)
3.570200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.176400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.138000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.100800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.299010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.604000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.234000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.038400E-01
Normal-vs-Daily Drinker
2.479200E-01
Normal-vs-Weekly Drinker
3.388400E-01
Normal-vs-Occasional Drinker
4.092000E-01
Normal-vs-Social Drinker
8.744000E-02
Non Drinker-vs-Daily Drinker
2.468400E-01
Non Drinker-vs-Weekly Drinker
6.516200E-01
Non Drinker-vs-Occasional Drinker
1.410180E-01
Non Drinker-vs-Social Drinker
3.403400E-01
Daily Drinker-vs-Weekly Drinker
1.615820E-01
Daily Drinker-vs-Occasional Drinker
1.459870E-02
Daily Drinker-vs-Social Drinker
6.533600E-02
Weekly Drinker-vs-Occasional Drinker
4.029600E-01
Weekly Drinker-vs-Social Drinker
6.685000E-01
Occasional Drinker-vs-Social Drinker
7.318800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.144100E-02
Normal-vs-Grade 2
1.515540E-02
Normal-vs-Grade 3
2.371800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.851800E-01
Grade 1-vs-Grade 3
3.460600E-01
Grade 1-vs-Grade 4
8.144100E-02
Grade 2-vs-Grade 3
4.654200E-01
Grade 2-vs-Grade 4
1.515540E-02
Grade 3-vs-Grade 4
2.371800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.422500E-02
Normal-vs-NonDiabetic
3.348600E-01
Diabetic-vs-NonDiabetic
9.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.079800E-01
Normal-vs-NoPancreatitis
3.348200E-01
Pancreatitis-vs-NoPancreatitis
6.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.765200E-01
Normal-vs-N1
3.233400E-01
N0-vs-N1
2.091000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.787800E-01
Normal-vs-TP53-NonMutant
5.566200E-01
TP53-Mutant-vs-TP53-NonMutant
5.880700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
